Drug Patent Expirations for Mar 23, 2017

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them

Click the patents below for more details, or visit DrugPatentWatch.com for more options.

VENLAFAXINE HYDROCHLORIDE (venlafaxine hydrochloride)
Osmotica Pharm
Patent number: 6,403,120
Expiration Date: Mar 20, 2017

VENLAFAXINE HYDROCHLORIDE (venlafaxine hydrochloride)
Osmotica Pharm
Patent number: 6,419,958
Expiration Date: Mar 20, 2017

SUMAVEL DOSEPRO (sumatriptan succinate)
Endo Ventures Ltd
Patent number: 6,135,979
Expiration Date: Mar 21, 2017

SYMBYAX (fluoxetine hydrochloride; olanzapine)
Lilly
Patent number: 5,945,416
Expiration Date: Mar 24, 2017

SOMAVERT (pegvisomant)
Pharmacia And Upjohn
Patent number: 5,849,535
Expiration Date: Mar 25, 2017

GEODON (ziprasidone mesylate)
Pfizer
Patent number: 6,110,918
Expiration Date: Mar 26, 2017

DrugPatentWatch provides instant access to actionable insights on pharmaceutical drugs.

For more information try a trial

Click here for reuse options!
Copyright 2017 Biotechblog

Leave a Reply

%d bloggers like this: